Transcripts Xilio Therapeutics, Inc.

Actions

Marché Fermé - Nasdaq 22:00:00 14/09/2026			Varia. 5j.	Varia. 1 janv.
8,930 ^USD	0,00 %		-0,78 %	-0,37 %

12/08	Xilio Therapeutics, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
29/06	Xilio Therapeutics, Inc. annonce la nomination de Ben Harshbarger au poste de directeur juridique	CI

11/11	Transcript : Xilio Therapeutics, Inc. - Special Call
12/02/25	Transcript : Xilio Therapeutics, Inc. - Special Call
22/01/25	Transcript : Xilio Therapeutics, Inc. - Special Call
07/11/24	Transcript : Xilio Therapeutics, Inc. - Special Call
04/09/24	Transcript : Xilio Therapeutics, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 07:00 AM
28/03/24	Transcript : Xilio Therapeutics, Inc. - Special Call
06/11/23	Transcript : Xilio Therapeutics, Inc. - Special Call
11/09/23	Transcript : Xilio Therapeutics, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 02:55 PM
17/08/23	Transcript : Xilio Therapeutics, Inc. - Special Call
23/02/23	Transcript : Xilio Therapeutics, Inc. Presents at Citi's 2023 Virtual Oncology Leadership Summit, Feb-23-2023 09:00 AM
01/12/22	Transcript : Xilio Therapeutics, Inc. - Special Call
13/09/22	Transcript : Xilio Therapeutics, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 02:55 PM